Personalized phage therapy at scale: why cost-effective infrastructure is the missing link – by José C. Santos and José L. Bila
more
The role of investigator initiated clinical trials in advancing antimicrobial use
more
The global relevance of NDM variants in antimicrobial resistance – by Clarisa Parodi and Alejandro J. Vila
more
Managing Acinetobacter baumannii infections: Continuing therapeutic challenges – by Mohamad Yasmin and Robert A. Bonomo
more
Global AMR Innovators Conference (GAMRIC) 2025
more